Bumper Offer - Urjas oil Just @ Rs. 1 X
Ziblok 25 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Angina, High BP. Other than this, Ziblok 25 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Ziblok 25 Mg Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Ziblok 25 Mg Tablet are Blurred vision, Cold hands. Some other side effects of Ziblok 25 Mg Tablet have been listed ahead. Usually, these side effects of Ziblok 25 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Ziblok 25 Mg Tablet's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Ziblok 25 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Ziblok 25 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Low Blood Pressure (Hypotension), Asthma are examples of such conditions. Other conditions have been mentioned below in the Ziblok 25 Mg Tablet contraindications section.
Drug reaction of Ziblok 25 Mg Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Ziblok 25 Mg Tablet is not safe while driving, and is not addiction.
Ziblok 25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ziblok 25 Mg Tablet is used -
Moderate
Mild
Common
Is the use of Ziblok 25 Mg Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Ziblok. If you are pregnant, do not take Ziblok without a doctor's advice.
Is the use of Ziblok 25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Ziblok. So it is adviced to consult the doctor before using it.
What is the effect of Ziblok 25 Mg Tablet on the Kidneys?
Very few cases of side effects of Ziblok on kidney have been reported.
What is the effect of Ziblok 25 Mg Tablet on the Liver?
Information about safety of Ziblok for the liver is not available since scientific research on this is yet to be done.
What is the effect of Ziblok 25 Mg Tablet on the Heart?
Very few cases of side effects of Ziblok on the heart have been reported.
Ziblok 25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ziblok 25 Mg Tablet unless your doctor advises you to do so -
Is this Ziblok 25 Mg Tablet habit forming or addictive?
Ziblok 25 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Ziblok 25 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Ziblok 25 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Ziblok 25 Mg Tablet is unable to treat or cure mental disorders.
Interaction between Food and Ziblok 25 Mg Tablet
Ziblok 25 Mg Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Ziblok 25 Mg Tablet
Taking Ziblok 25 Mg Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198